Time Burden of Prostate Cancer Treatment

What’s the time burden of prostate cancer treatment? How does a diagnosis of prostate cancer affect how you spend your personal time or your work time?

Your oncologist or urologist can talk to you about your treatment and therapies. Your fellow PCa patients and survivors can talk to you about possible side effects and how you may feel while on treatment. But what is the time burden of prostate cancer treatment?

The time burden of prostate cancer treatment can be substantial and varies widely depending on disease stage, treatment type, side-effect management, and survivorship needs. Below is a structured, patient-centered overview showing where time is typically spent across the care continuum.

1. Diagnostic Phase (Weeks to Months)

Estimated time burden: ~10–30 hours total

Includes:

PSA testing and repeat labs
Imaging (MRI, CT, bone scan)
Prostate biopsy (procedure + recovery)
Specialist consultations (urology, radiation oncology, medical oncology)
Decision-making and second opinions

⏱️ Often involves multiple appointments over several weeks, plus anxiety-driven time spent researching and deliberating.

2. Active Treatment Phase (Varies by Modality)

A. Surgery (Radical Prostatectomy)

Time burden: ~40–80 hours over 6–8 weeks

Pre-op testing and clearance
Surgery day (full day)
Hospital stay (1–2 days)
Post-op visits (2–4)
Catheter management and recovery time
Pelvic floor physical therapy (weeks–months)

⏱️ Recovery may limit work and daily activities for 4–8 weeks.

B. Radiation Therapy

External Beam Radiation (IMRT / Proton)

Time burden: ~60–90 hours over 6–9 weeks

Planning scans and simulation
Daily treatments (5 days/week)
- ~15–30 minutes per visit
- Travel time often exceeds treatment time
Weekly on-treatment visits

⏱️ One of the largest cumulative time burdens due to daily attendance.

Brachytherapy

Time burden: ~10–20 hours total

Pre-procedure planning
One outpatient procedure
Follow-up visits

C. Androgen Deprivation Therapy (ADT)

Time burden: ~10–25 hours per year

Injection visits every 1–6 months
Lab monitoring
Side-effect management (fatigue, metabolic changes, sexual health)

⏱️ Ongoing but less appointment-dense; indirect burden from fatigue is common.

D. Advanced / Metastatic Disease

Time burden: ~5–15 hours/month (or more)

Includes:

Systemic therapies (chemotherapy, novel hormonal agents)
Imaging every 2–4 months
Palliative care visits
Symptom management

3. Survivorship & Long-Term Management (Years to Lifetime)

Time burden: ~10–30 hours per year

PSA monitoring (every 3–12 months)
Management of long-term side effects:
- Urinary incontinence
- Erectile dysfunction
- Bowel symptoms
Physical therapy, sexual health counseling
Mental health support

⏱️ Many men describe this as a chronic, low-level time burden rather than episodic care.

4. Indirect & Hidden Time Costs (Often Overlooked)

These frequently exceed medical appointment time:

Travel and parking
Time off work (patient and caregiver)
Care coordination and insurance navigation
Lifestyle adjustments (exercise, diet, symptom tracking)
Emotional and cognitive load (“illness work”)

Summary Table (Approximate)

Phase	Typical Time Burden
Diagnosis	10–30 hours
Surgery (if chosen)	40–80 hours
Radiation (EBRT)	60–90 hours
ADT (annual)	10–25 hours
Survivorship (annual)	10–30 hours
Advanced disease	5–15+ hours/month

Key Takeaway

Prostate cancer treatment often involves a moderate to high time burden, especially during radiation therapy and early recovery phases. Even in survivorship, care demands persist for years, making prostate cancer a chronic, time-intensive condition rather than a one-time event.

I am a long-term survivor of an incurable blood cancer called multiple myeloma. The time burden for my treatments varied widely over the first 5 years of my treatment. So I thought PCa patients should get a sense of what they were in for.

Scroll down the page, post a question or comment if you would like to learn more about evidence-based PCa complementary therapies such as diet, supplements, and lifestyle.

Good luck,

David Emerson

Cancer Survivor
Cancer Coach
Director PeopleBeatingCancer

Ten‐year work burden after prostate cancer treatment

Introduction

We aim to characterize the magnitude of the work burden (weeks off from work) associated with prostate cancer (PCa) treatment over a 10‐year period after PCa diagnosis and identify those at greatest risk.

Materials and Methods

We identified men diagnosed with PCa treated with radical prostatectomy, radiation therapy, or active surveillance/watchful waiting within CaPSURE. Patients self‐reported work burden and SF36 general health scores via surveys before and 1,3,5, and 10 years after treatment. Using multivariate repeated measures generalized estimating equation modeling, we examined the association between primary treatment with risk of any work weeks lost due to care.

Results

In total, 6693 men were included. The majority were White (81%, 5% Black, and 14% Other) with CAPRA low‐ (60%) or intermediate‐risk (32%) disease and underwent surgery (62%) compared to 29% radiation and 9% active surveillance. Compared to other treatments, surgical patients were more likely to report greater than 7 days off work in the first year, with relatively less time off over time. Black men (RR 0.64, 95% CI 0.54–0.77) and those undergoing radiation (vs. surgery, RR 0.46, 95% CI 0.41–0.51) were less likely to report time off from work over time. Mean baseline GH score (73 [SD 18]) was similar between race and treatment groups, and stable over time.

Conclusions

The work burden of cancer care continued up to 10 years after treatment and varied across racial groups and primary treatment groups, highlighting the multifactorial nature of this issue and the call to leverage greater resources for those at greatest risk.

time burden of prostate cancer treatment time burden of prostate cancer treatment